Related Experiment Video
Updated: Aug 17, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Correlations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development
1Medicine Branch, National Cancer Institute, NIH, Bethesda, MD 20892.
Abstract:
Some 10 years after the first recognition of acquired immunodeficiency syndrome (AIDS) as a new syndrome, we have identified a number of molecular targets to interrupt the replicative cycle of human immunodeficiency virus (HIV), the causative agent. A number of dideoxynucleosides have been identified as having anti-HIV activity in vitro, and several of these have been found to have clinical activity in patients. In contrast, while a number of agents have been found to block viral binding to the target cell in vitro, these agents have generally not shown clear-cut evidence of clinical activity. Agents which act at a variety of steps in the HIV replicative cycle are now under development, and it is likely that we will have an increased armamentarium to fight this disease in the near future.
Related Concept Videos
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Equivalence: In Vitro and In Vivo Bioequivalence
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Product Performance: In Vitro–In Vivo Correlation
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Inhibitors of Virion Maturation and Assembly

